4.7 Review

The Cardioprotective Signaling Activity of Activated Protein C in Heart Failure and Ischemic Heart Diseases

Journal

Publisher

MDPI
DOI: 10.3390/ijms20071762

Keywords

activated protein C; endothelial protein C receptor; heart failure; ischemic heart disease; cardioprotection

Funding

  1. National Heart, Lung, and Blood Institute of the National Institutes of Health [HL101917, HL062565]
  2. National Heart, Lung, and Blood Institute [P01HL051971]
  3. National Institute on Aging [AG049835]
  4. National Institute of General Medicine [GM124108, P20GM104357]

Ask authors/readers for more resources

Activated protein C (APC) is a vitamin-K dependent plasma serine protease, which functions as a natural anticoagulant to downregulate thrombin generation in the clotting cascade. APC also modulates cellular homeostasis by exhibiting potent cytoprotective and anti-inflammatory signaling activities. The beneficial cytoprotective effects of APC have been extensively studied and confirmed in a number of preclinical disease and injury models including sepsis, type-1 diabetes and various ischemia/reperfusion diseases. It is now well-known that APC modulates downstream cell signaling networks and transcriptome profiles when it binds to the endothelial protein C receptor (EPCR) to activate protease-activated receptor 1 (PAR1) on various cell types. However, despite much progress, details of the downstream signaling mechanism of APC and its crosstalk with other signaling networks are far from being fully understood. In this review, we focus on the cardioprotective properties of APC in ischemic heart disease and heart failure with a special emphasis on recent discoveries related to the modulatory effect of APC on AMP-activated protein kinase (AMPK), PI3K/AKT, and mTORC1 signaling pathways. The cytoprotective properties of APC might provide a novel strategy for future therapies in cardiac diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway

Qingguo Lu, Jia Liu, Xuan Li, Xiaodong Sun, Jingwen Zhang, Di Ren, Nanwei Tong, Ji Li

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice

Xiaodong Sun, Fang Han, Qingguo Lu, Xuan Li, Di Ren, Jingwen Zhang, Ying Han, Yang K. Xiang, Ji Li

DIABETES (2020)

Article Biochemistry & Molecular Biology

SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion

Ying Han, Weiju Sun, Di Ren, Jingwen Zhang, Zhibin He, Julia Fedorova, Xiaodong Sun, Fang Han, Ji Li

REDOX BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Sestrin2 modulates cardiac inflammatory response through maintaining redox homeostasis during ischemia and reperfusion

Di Ren, Nanhu Quan, Julia Fedorova, Jingwen Zhang, Zhibin He, Ji Li

REDOX BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Substrate metabolism regulated by Sestrin2-mTORC1 alleviates pressure overload-induced cardiac hypertrophy in aged heart

Nanhu Quan, Xuan Li, Jingwen Zhang, Ying Han, Weiju Sun, Di Ren, Qian Tong, Ji Li

REDOX BIOLOGY (2020)

Review Biochemistry & Molecular Biology

SIRT1/SIRT3 Modulates Redox Homeostasis during Ischemia/Reperfusion in the Aging Heart

Jingwen Zhang, Di Ren, Julia Fedorova, Zhibin He, Ji Li

ANTIOXIDANTS (2020)

Article Biochemistry & Molecular Biology

Sestrin2 maintains OXPHOS integrity to modulate cardiac substrate metabolism during ischemia and reperfusion

Di Ren, Zhibin He, Julia Fedorova, Jingwen Zhang, Elizabeth Wood, Xiang Zhang, David E. Kang, Ji Li

Summary: Sesn2, a stress-inducible protein, declines with aging in the heart. Lack of Sesn2 results in cardiac aging-like dysfunction and intolerance to ischemia reperfusion stress. Sesn2 deficiency impairs mitochondrial function and affects oxidative phosphorylation complex activity, impacting the maintenance of cardiac mitochondrial integrity.

REDOX BIOLOGY (2021)

Article Cell Biology

Alterations in mitochondrial dynamics with age-related Sirtuin1/Sirtuin3 deficiency impair cardiomyocyte contractility

Jingwen Zhang, Zhibin He, Julia Fedorova, Cole Logan, Lauryn Bates, Kayla Davitt, Van Le, Jiayuan Murphy, Melissa Li, Mingyi Wang, Edward G. Lakatta, Di Ren, Ji Li

Summary: SIRT1 and SIRT3 play critical roles in protecting cardiac function against ischemia/reperfusion injury by maintaining mitochondrial homeostasis, particularly mitochondrial dynamics. Deficiency of SIRT1 and SIRT3 results in impaired mitochondrial respiration and contractile function of cardiomyocytes under I/R stress, highlighting their importance in cardiac health.

AGING CELL (2021)

Article Cardiac & Cardiovascular Systems

Activated Protein C Strengthens Cardiac Tolerance to Ischemic Insults in Aging

Di Ren, Julia Fedorova, Kayla Davitt, Tran Ngoc Van Le, John H. Griffin, Patricia Chia-Ying Liaw, Charles Esmon, Alireza R. Rezaie, Ji Li

Summary: This study investigates the role of the APC-EPCR axis in ischemic insults in aging. The results show that APC activity is reduced during cardiac ischemia and reperfusion, and this reduction is more pronounced in aged hearts. Administration of APC prevents the shedding of EPCR induced by I/R and improves cardiac dysfunction in both young and aged mice. However, these cardioprotective effects of APC are diminished in EPCRR84A/R84A mice. AMPK mediates acute adaptive response while AKT is involved in chronic metabolic programming in APC-treated hearts.

CIRCULATION RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Age-Independent Cardiac Protection by Pharmacological Activation of Beclin-1 During Endotoxemia and Its Association With Energy Metabolic Reprograming in Myocardium-A Targeted Metabolomics Study

Matthew Kim, Azadeh Nikouee, Raymond Zou, Di Ren, Zhibin He, Ji Li, Lu Wang, Danijel Djukovic, Daniel Raftery, Hayley Purcell, Daniel Promislow, Yuxiao Sun, Mohammad Goodarzi, Qing-Jun Zhang, Zhi-Ping Liu, Qun Sophia Zang

Summary: This study demonstrates that TB-peptide, through activating Beclin-1, provides cardiac protection against endotoxemia in both young and aged populations. Metabolomics analysis suggests that the protective effect of TB-peptide, independent of age, is associated with reprogramming of energy production via glucose and amino acid metabolisms.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Cell Biology

Targeting on Nrf2/Sesn2 Signaling to Rescue Cardiac Dysfunction during High-Fat Diet-Induced Obesity

Meredith Krause-Hauch, Julia Fedorova, Linda Ines Zoungrana, Hao Wang, Mohammad Kasim Fatmi, Zehui Li, Migdalia Iglesias, Lily Slotabec, Ji Li

Summary: This study aims to explore the interconnection between Nrf2 and Sesn2 during obesity-related stress and its role in cardio-protection. The results showed that the overexpression of Sesn2 has cardio-protective effects on the obese heart by reducing ROS and fibrosis and improving cardiac function. Similar results were observed in human heart samples. However, there was no observable pattern of Sesn2/Nrf2 expression in mouse samples.

CELLS (2022)

Article Biochemistry & Molecular Biology

Sirtuin 1 aggravates hypertrophic heart failure caused by pressure overload via shifting energy metabolism

Ji Li, Tran Ngoc Van Le, Linda Ines Zoungrana, Hao Wang, Mohammad Kasim Fatmi, Di Ren, Meredith Krause-Hauch

Summary: SIRT1 plays a critical role in regulating substrate metabolism in the cardiovascular system. Cardiac SIRT1 can modulate substrate metabolism during pressure overload-induced heart failure by interfering with mitochondrial IDH2. Inhibition of SIRT1 activity benefits cardiac functions under pressure overload-related pathological conditions.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Cell Biology

Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging

Mohammad Kasim Fatmi, Di Ren, Julia Fedorova, Linda Ines Zoungrana, Hao Wang, Kayla Davitt, Zehui Li, Migdalia Iglesias, Edward J. Lesnefsky, Meredith Krause-Hauch, Ji Li

Summary: Ischemic heart disease (IHD) is the leading cause of death, with age being a major factor. Single-cell RNA sequencing was used to identify transcriptional differences between aged and young mice, providing insights into the vulnerability of the aged heart to ischemic insult.

AGING CELL (2023)

Article Cell Biology

Sestrin2 Mediates Metformin Rescued the Age-Related Cardiac Dysfunctions of Cardiorenal Syndrome Type 3

Migdalia Iglesias, Hao Wang, Meredith Krause-Hauch, Di Ren, Linda Ines Zoungrana, Zehui Li, Jie Zhang, Jin Wei, Nikita Yadav, Kshama Patel, Mohammad Kasim Fatmi, Ruisheng Liu, Edward J. Lesnefsky, Ji Li

Summary: Acute kidney injury (AKI) leads to acute cardiac injury and dysfunction in cardiorenal syndrome Type 3 (CRS3) through oxidative stress (OS). The stress-inducible Sestrin2 (Sesn2) protein reduces reactive oxygen species (ROS) accumulation and activates AMP-dependent protein kinase (AMPK) to regulate cellular metabolism and energetics during OS. Sesn2 levels and its protective effects decline in the aged heart. Antidiabetic drug metformin upregulates Sesn2 levels in response to ischemia-reperfusion (IR) stress. However, the role of metformin in CRS3 remains unknown. This study seeks to explore how the age-related decrease in cardiac Sesn2 levels contributes to cardiac intolerance to AKI-induced insults, and how metformin ameliorates CRS3 through Sesn2.

CELLS (2023)

No Data Available